{
  "id": 20909293,
  "title": "Big Pharma, with eye on Anthropic, says AI is shrinking drug discovery timelines",
  "url": "https://urgent.news/2026/11/20/big-pharma-with-eye-on-anthropic-says-ai-is-shrinking-drug-discovery-20909293",
  "topic": "ai",
  "section": "AI",
  "published": "2026-11-20T14:30:29.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/stock-market-news/big-pharma-with-eye-on-anthropic-says-ai-is-shrinking-drug-discovery-timelines-5041287"
  },
  "original_language": "en",
  "account": "Artificial intelligence is revolutionizing early-stage drug development, cutting timelines by up to half, according to top scientists at major pharmaceutical companies. GSK, Bristol Myers Squibb, Novartis, Eli Lilly, Novo Nordisk, AstraZeneca, and Sanofi are no longer using AI for mundane tasks; instead, they are employing it to design molecules, identify the most promising candidates, and detect safety risks. AstraZeneca's Sharon Barr stated that AI is now integrated into every stage of the discovery and development pipeline. Despite Anthropic's $1.5 trillion IPO this week, the company faces competition from industry giants with decades of experience and data. While Anthropic's CEO Dario Amodei believes AI can accelerate drug development and potentially cure diseases faster, some drug companies remain cautious. They acknowledge AI's potential to make drug development more efficient, estimating a 20% to 25% reduction in early-discovery timelines within the next two years and possibly half within five years. However, they also point out that bottlenecks in human trials and regulatory approval could limit the speed of successful drug approval.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "CNA - Business",
        "title": "Big Pharma, with eye on Anthropic, says AI is shrinking drug discovery timelines",
        "url": "https://urgent.news/2026/11/20/big-pharma-with-eye-on-anthropic-says-ai-is-shrinking-drug-discovery",
        "published": "2026-11-20T11:01:45.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}